The AAP issued a policy statement at the beginning of 2023 recommending that physicians offer weight-loss medication to adolescents aged 12 years or older and evaluate teens for bariatric and metabolic surgery
The liver breaks down alcohol, but the process can generate harmful substances that damage liver cells and promote inflammation
The tumor suppressor protein p53 and the ferroptosis network
Obesity and visceral adiposity are key drivers of HFpEF development and progression, and this may be even more amplified in women, who represent the majority of people with the disease, and bear a heavier burden of symptoms and physical limitations due to HFpEF, says Mikhail Kosiborod, MD, FACC, senior author of the study and a cardiologist at Saint Lukes Mid-America Heart Institute
GLP-1 Medications: Setting Realistic Expectations It is important to be transparent: food-based GLP-1 support operates at a different magnitude than GLP-1 receptor agonist medications like semaglutide
Novo Nordisk, the maker of these weight-loss drugs, does not include warnings about the increased risk of gastroparesis/stomach paralysis (frozen stomach) for people who consume the medications or receive GLP-1 RA treatments
